Results of prostate cancer screening in non-symptomatic men
Brazilian Journal of Urology, v. 27, n. 3, p. 227-234, 2001.
Antonopoulos, I. M.
Pompeo, A. C. L.
El Hayek, O. R.
Sarkis, A. S.
Objectives: To verify prostate cancer prevalence in non-symptomatic men between 50 and 70 years old as well as cancer characteristics. Material and Methods: 2815 non-symptomatic men had total PSA and digital rectal examination performed between March 1998 and April 1998. Racial distribution was: 2331 Caucasians (83.9%), 373 Blacks (13.4%) and 75 Asiatic (2.7%). PSA was normal in 2554 (91.4%), 4 to 10 in 177 (6.3%) and greater than 10 in 64 (2.3%). DRE was normal in 2419 (86.3%), suspicious in 347 (12.4%) and characteristic for cancer in 37 (1.3%). Men with abnormal DRE and/or PSA had transrectal prostate biopsy indicated. Results: 461 biopsies were done and 78 tumors was detected (prevalence = 2.8%). Prevalence was progressively higher with age (p < 0.001), PSA level (p < 0.0001) and DRE findings (p = 0.0216). Cancer prevalence in Blacks was 1.65 times higher than in Caucasians (p > 0.05) and 94.9% of detected tumors were moderately or poorly differentiated. Sensibility, specificity, positive predictive value, negative predictive value and total accuracy for PSA were respectively: 66.6%; 89.7%; 51.7%; 94.2% and 86.5%. For DRE, the respective values were: 49.1%; 79.4%; 50.9%; 78.3% and 70.3%. Conclusions: prostate cancer prevalence in the studied population (2.8%) was similar to that of other countries populations. Cancer prevalence in blacks was 1.65 times higher than in Caucasians (difference was not statistically significant). Cancer prevalence becomes higher with aging. The association of DRE and PSA is of paramount importance for cancer diagnosis. The great majority of detected tumors (94.9%) was moderately and poorly differentiated. Brazil probably needs regional studies to better characterize prostate cancer epidemiology due to population heterogeneity.
Showing items related by title, author, creator and subject.
Cuestionarios de calidad de vida en cáncer de próstata quirúrgico: University of California-Los Angeles-Prostate Cancer Index (UCLA-PCI) vs. Expanded Prostate Cancer Index (EPIC) vs. Cuestionario Calidad de Vida en Pacientes con Cáncer de Próstata (CAVIPRES) Leon-Miranda, B.; Roca Quicaño, Ricardo; Chavez Porras, A.
Strategies To Evaluate The Impact Of Rectal Volume On Prostate Motion During Three-dimensional Conformal Radiotherapy For Prostate Cancer Poli A.P.D.F.; Dias R.S.; Giordani A.J.; Segreto H.R.C.; Segreto R.A.
Prostate cancer screening in the fit chilean elderly: A head to head comparison of total serum PSA versus age adjusted PSA versus primary circulating prostate cells to detect prostate cancer at initial biopsy Murray, Nigel P. [Chile. Universidad Mayor. Facultad de Medicina]; Reyes, Eduardo [Chile. Hospital DIPRECA]; Orellana, Nelson [Hospital de Carabineros de Chile]; Fuentealba, Chyntia [Hospital de Carabineros de Chile]; Jacob, Omar [Hospital de Carabineros de Chile] (Facultad de Ciencias, 2015)BACKGROUND: Prostate cancer is predominately a disease of older men, with a median age of diagnosis of 68 years and 71% of cancer deaths occurring in those over 75 years of age. While prostate cancer screening is not ...